Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: Relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients

Pharmacogenetics

Volumn 8, Issue 5, 1998, Pages 441-447

  Kristensen, Vessela Nedelcheva ^a   Andersen, Tone Ikdahl ^a,b   Erikstein, Bjørn ^a   Geitvik, Gry ^a   Skovlund, Eva ^c   Nesland, Jahn M ^a   Børresen Dale, Anne Lise ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Breast cancer risk; GSTM1; GSTP1; GSTT1; Loss of heterozygosity; TP53

Indexed keywords

GLUTATHIONE TRANSFERASE; ISOENZYME; PROTEIN P53;

ARTICLE; BREAST CANCER; CANCER CELL; CHROMOSOME 17; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE LOCUS; GENE MAPPING; GENETIC ANALYSIS; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; GENE FREQUENCY; GENES, P53; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE DELETION;

EID: 0012792697     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199810000-00009     Document Type: Article

References (26)

1. Aas T, Borresen A-L, Geisler S, Johnsen H, Varhaug JE, Akslen LA, Lonning PE. Specific TP53 mutations are associated with de novo resistance to doxorubicin therapy in breast cancer patients. Nature Med 1996; 2:811-814.
2. Andersen TI, Gaustad A, Ottestad L, Farrants GW, Nesland J, Tveit KM, Borresen A-L. Genetic alterations of tumor suppressor gene regions 3p, 11p, 13q, 17p, in human breast carcinomas. Genes Chromosomes Cancer 1992; 4:13-121.
3. Andersen TI, Holm R, Nesland JM, Heimdal KR, Ottestad L. Borrensen A-L. Prognostic significance of TP 53 alterations in breast carcinoma. Br J Cancer 1993; 6:540-548.
4. Ban N, Takahashi Y, Takayama T, Kura T, Katahira T, Sakamaki S, Nitsu Y. Transfection of glutathione S transferase p- antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cis-platin, melphalan and etoposide. Cancer Res 1996; 56:3577-3582.
5. Brokmöller J, Kaiser R, Kerb R, Cascorbi I, Jaeger V, Roots I. Polymorphic enzymes of xenobiotic metabolism as modulators of acquired p53 mutations in bladder cancer. Pharmacogenetics 1996; 6:535-545.
6. Chow NW, Whang Peng J, Kao-Shan CS, Tam MF, Lai HCJ, Tu CPD. Human glutathione S-transferases. The nultigene family encodes products of different but overlapping specificities. J Biol Chem 1988; 263:12797-12800.
7. Comstock KE, Sanderson BJC, Claflin G, Henner WD. GST1 gene deletion determined by polymerase chain reaction. Nucleic Acid Res 1990; 18:3670.
8. Elston CW, Ellis IO. Pathologic prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study, with long term follow up. Histopathology 1991; 19:403-410.
9. Gibbs JP, Czerwinski M, Slattery JT. Busulphan-glutathione conjugation catalysed by human liver cytosolic glutathione S transferases. Cancer Res 1996; 56:3678-3681.
10. Gilbert L, Elwood L, Merino M, Masood SH, Barnes R, Steinberg SM, Lazarous DF, et al. A pilot study of Pi-class glutathione S transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node Inegative breast cancer. J Clinical Oncol 1993; 11:49-58.
11. Goto I, Yoneda S, Yamamoto M, Kawajiri K. Prognostic significance of germline polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small lung cell cancer. Cancer Res 1996; 56:3725-5730.
12. Hartman A, Blaszyk H, Kovach JS, Sommer S. The molecular epidemiology of P53 gene mutations in human breast cancer. Trends Gen 1997; 13:27-33.
13. Hirvonen A, Pelin A, Tammilehto L, Karjalainen A, Mattson A, Linnainma A. Inherited GSTM1 and NAT2 defects as concurrent risk modifyers in asbestos related human malignant mezonthelioma. Cancer Res 1995; 55:2981-2983.
14. Hou SM, Lambert B, Hemminki K. Relationship between hgprt mutant frequency, aromatic DNA adducts and genotypes for GSTM1 and NAT2 in bus maintenance workers. Carcinogenesis 1995; 16:1913-1917.
15. Hoyheim N, Nakamura Y, White R. A BamH1 polymorphism is detected by a genomic p53 clone (pBHP53). Nucleic Acid Res 1989; 17:8898.
16. Kelley MK, Enqvist-Goldstein Å, Montali J, Wheatley JB, Schmidt Jr DE, Kauar LM. Variability of Glutathione S-transferase isoenzyme patterns in matched normal and cancer breast human tissue. Biochemical J 1994; 304:843-848.
17. Lee WP, Lee CL, Lin HC. Gluthatione S transferase and gluthatione peroxidase are essential in the early stage of adriamycin resistance before P-glycoprotein overexpression in HOB1 lymphoma cells. Cancer Chemother Pharmacol 1996; 38:45-51.
18. Malins DC, Polissar NL, Gunselman SJ. Progression of human breast cancers to the metastatic state is linked to hydroxyl radical-induced DNA damage. Proc. Natl Acad Sci 1996; 93:2557-2563.
19. Miyara H, Hida T, Nishida K, Takashi T, Sugiura T, Ariyoshi Y, et al. Modification of chemoradiosensitivity of a human lung cancer cell line by the introduction of the Glutathione S-transferase p gene. Jpn J Clin Oncol 1996; 26:1-5.
20. Penible S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, et al. Human glutathione transferase Theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994; 300:271-276.
21. Rebbeck T. Molecular epidemiology of the human glutathione S transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Preven 1997; 6:733-743.
22. Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf RC, et al. Combined genotypes of glutathione S-transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 1997; 18:1285-1289.
23. Sarhanis P, Redman C, Perret C, Brannigan K, Clayton RN, Hand P, et al. Epithelial ovarian cancer: influence of polymorphism at the Glutathione-S-transferase GSTM1 and GSTT1 loci on p53 expression. Br J Cancer 1996; 74:1757-1761.
24. Warcholm M, Aleksandre AK, Hogberg J, Sigvardsonn K, Rannung A. Polymorphic distribution of glutathione S transferase activity with methyl chloride in human blood. Pharmacogenetics 1994; 4:307-311.
25. Wiencke JK, Pemble S, Ketterer B, Kelsey KT. Gene deletion of glutathione S transferase 6: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prev 1995; 4:234-259.
26. Zimniak P, Nanduri B, Pikula S, Bandorowitcz-Pikula J, Singhal SS, Skrivastava SK, Awasthi YC. Naturally occurring human glutathione S transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymatic properties. Eur J Biochem 1994; 224:893-899.